Literature DB >> 19833392

Complement inhibition accelerates regeneration in a model of peripheral nerve injury.

Valeria Ramaglia1, Martijn Rudolf Tannemaat, Maryla de Kok, Ruud Wolterman, Miriam Ann Vigar, Rosalind Helen Mary King, Bryan Paul Morgan, Frank Baas.   

Abstract

Complement (C) activation is a crucial event in peripheral nerve degeneration but its effect on the subsequent regeneration is unknown. Here we show that genetic deficiency of the sixth C component, C6, accelerates axonal regeneration and recovery in a rat model of sciatic nerve injury. Foot-flick test and Sciatic Function Index monitored up to 5 weeks post-injury showed a significant improvement of sensory and motor function in the C6 deficient animals compared to wildtypes. Retrograde tracing experiments showed a significantly higher number of regenerated neurons at 1 week post-injury in C6 deficient rats than wildtypes. Pathology showed improved nerve regeneration in tibials of C6 deficient animals compared to wildtypes. Reconstitution with purified human C6 protein re-established the wildtype phenotype whereas pharmacological inhibition of C activation with soluble C receptor 1 (sCR1) facilitated recovery and improved pathology similarly to C6 deficient animals. We suggest that a destructive C-mediated event during nerve degeneration hampers the subsequent regenerative process. These findings provide a rationale for the testing of anti-complement agents in human nerve injury.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833392     DOI: 10.1016/j.molimm.2009.09.019

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  13 in total

1.  A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy.

Authors:  Marian A J Weterman; Vincenzo Sorrentino; Paul R Kasher; Marja E Jakobs; Baziel G M van Engelen; Kees Fluiter; Marit B de Wissel; Aleksander Sizarov; Gudrun Nürnberg; Peter Nürnberg; Noam Zelcer; H Jurgen Schelhaas; Frank Baas
Journal:  Hum Mol Genet       Date:  2011-10-19       Impact factor: 6.150

2.  Retinal Ganglion Cell Axon Regeneration Requires Complement and Myeloid Cell Activity within the Optic Nerve.

Authors:  Sheri L Peterson; Yiqing Li; Christina J Sun; Kimberly A Wong; Kylie S Leung; Silmara de Lima; Nicholas J Hanovice; Kenya Yuki; Beth Stevens; Larry I Benowitz
Journal:  J Neurosci       Date:  2021-08-20       Impact factor: 6.167

3.  M. leprae components induce nerve damage by complement activation: identification of lipoarabinomannan as the dominant complement activator.

Authors:  Nawal Bahia El Idrissi; Pranab K Das; Kees Fluiter; Patricia S Rosa; Jeroen Vreijling; Dirk Troost; B Paul Morgan; Frank Baas; Valeria Ramaglia
Journal:  Acta Neuropathol       Date:  2015-03-15       Impact factor: 17.088

4.  Complement activation at the motor end-plates in amyotrophic lateral sclerosis.

Authors:  Nawal Bahia El Idrissi; Sanne Bosch; Valeria Ramaglia; Eleonora Aronica; Frank Baas; Dirk Troost
Journal:  J Neuroinflammation       Date:  2016-04-07       Impact factor: 8.322

5.  Facial Nerve Recovery in KbDb and C1q Knockout Mice: A Role for Histocompatibility Complex 1.

Authors:  Seden Akdagli; Ryan A Williams; Hyun J Kim; Yuling Yan; Mirna Mustapha; Sam P Most
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-12-23

Review 6.  Useful Effects of Melatonin in Peripheral Nerve Injury and Development of the Nervous System.

Authors:  Yigit Uyanikgil; Turker Cavusoglu; Kubilay Dogan Kılıc; Gurkan Yigitturk; Servet Celik; Richard Shane Tubbs; Mehmet Turgut
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2017-02-16

7.  In Situ complement activation and T-cell immunity in leprosy spectrum: An immunohistological study on leprosy lesional skin.

Authors:  Nawal Bahia El Idrissi; Anand M Iyer; Valeria Ramaglia; Patricia S Rosa; Cleverson T Soares; Frank Baas; Pranab K Das
Journal:  PLoS One       Date:  2017-05-15       Impact factor: 3.240

8.  The complement system in hypertension and renal damage in the Dahl SS rat.

Authors:  Jean F Regal; Connor F Laule; Luke McCutcheon; Kate M Root; Hayley Lund; Shireen Hashmat; David L Mattson
Journal:  Physiol Rep       Date:  2018-03

9.  No association between systemic complement activation and intensive care unit-acquired weakness.

Authors:  Esther Witteveen; Luuk Wieske; Friso M de Beer; Nicole P Juffermans; Camiel Verhamme; Marcus J Schultz; Ivo N van Schaik; Janneke Horn
Journal:  Ann Transl Med       Date:  2018-04

Review 10.  PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to Pressure Palsies.

Authors:  Barbara W van Paassen; Anneke J van der Kooi; Karin Y van Spaendonck-Zwarts; Camiel Verhamme; Frank Baas; Marianne de Visser
Journal:  Orphanet J Rare Dis       Date:  2014-03-19       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.